Deputy General Counsel

Shannon Shanahan is responsible for managing MVI’s legal matters, including providing legal, business, and strategic counsel. Shannon led MVI’s legal efforts for the RTS,S Phase 3 malaria vaccine trials in Africa.

Shannon brings more than 20 years of legal experience, having worked for multinational, public, and private companies in the biotechnology and technology sectors. Her legal experience includes taking a drug candidate from preclinical development to market, developing and implementing compliance plans, risk management, and negotiating and drafting complex agreements with an intellectual property emphasis.

Prior to joining PATH, Shannon was director of corporate legal affairs at Cell Therapeutics, Inc. (CTI), a multinational, public biotechnology company, where she managed the corporate legal department and the legal work for CTI and its six subsidiaries. Shannon supported CTI’s international Phase 3 clinical programs, including US and European regulatory filings and product launch for Trisenox™. Prior to CTI, Shannon worked as a corporate attorney for Chiroscience/Celltech, a UK multinational, public biopharmaceutical company, where she provided legal counsel to senior management, subsidiaries, and department heads. Shannon also worked as legal counsel for technology companies in the internet and software fields. Shannon has lectured and presented on various legal topics including: legal risks in international clinical trials, contract drafting and negotiations, and litigation of intellectual property.

Shannon holds a JD from Gonzaga Law School and a BA in political science from California Polytechnic State University. Prior to obtaining her JD, Shannon worked in the nonprofit sector in San Luis Obispo, CA.